Anat Shirvan
Research Interests
Anat Shirvan has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Ilan Ziv
NeuroSurvival Technologies (NST) Ltd., Petach-Tikva, Israel
2 shared publicationsAri Barzilai
From the ‡Department of Neurology and the Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, and the Sackler School of Medicine, Petach Tiqva 49100 and the ¶Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, the ‖Department of Cell Research and Immunology, and the **Sam Rothberg Glaucoma Center, Goldschleger Eye Research Institute, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel
1 shared publication- Ari Barzilai
Department of Neurobiology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 69978, Israel
1 shared publication Arieh S. Solomon
From the ‡Department of Neurology and the Felsenstein Medical Research Center, Rabin Medical Center, Beilinson Campus, and the Sackler School of Medicine, Petach Tiqva 49100 and the ¶Department of Neurobiochemistry, George S. Wise Faculty of Life Sciences, the ‖Department of Cell Research and Immunology, and the **Sam Rothberg Glaucoma Center, Goldschleger Eye Research Institute, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel
1 shared publicationAvi Cohen
NeuroSurvival Technologies (NST) Ltd., Petach-Tikva, Israel
1 shared publicationAyelet Reshef
NeuroSurvival Technologies (NST) Ltd., Petach-Tikva, Israel
1 shared publication
Latest Publications
- Open Access
- 17 October 2006
- Published by Springer Nature in Apoptosis
- Vol. 11 (12) , 2089-2101
Molecular imaging of cell death in vivo by a novel small molecule probe
Apoptosis has a role in many medical disorders, therefore assessment of apoptosis in vivo can be highly useful for diagnosis, follow-up and evaluation of treatment efficacy. ApoSense is a novel technology, comprising low molecular-weight probes, specifically designed for imaging of cell death in vivo. In the current study we present targeting and imaging of cell death both in vitro and in vivo, utilizing NST-732, a member of the ApoSense family, comprising a fluorophore and a fluorine atom, for both fluorescent and future positron emission tomography (PET) studies using an 18F label, respectively. In vitro, NST-732 manifested selective and rapid accumulation within various cell types undergoing apoptosis. Its uptake was blocked by caspase inhibition, and occurred from the early stages of the apoptotic process, in parallel to binding of Annexin-V, caspase activation and alterations in mitochondrial membrane potential. In vivo, NST-732 manifested selective uptake into cells undergoing cell-death in several clinically-relevant models in rodents: (i) Cell-death induced in lymphoma by irradiation; (ii) Renal ischemia/reperfusion; (iii) Cerebral stroke. Uptake of NST-732 was well-correlated with histopathological assessment of cell-death. NST-732 therefore represents a novel class of small-molecule detectors of apoptosis, with potential useful applications in imaging of the cell death process both in vitro and in vivo.
- 17 October 2006
- Published by Springer Nature in Apoptosis
- Vol. 11 (12) , 2089-2101
Open AccessMolecular imaging of cell death in vivo by a novel small molecule probe
Apoptosis has a role in many medical disorders, therefore assessment of apoptosis in vivo can be highly useful for diagnosis, follow-up and evaluation of treatment efficacy. ApoSense is a novel technology, comprising low molecular-weight probes, specifically designed for imaging of cell death in vivo. In the current study we present targeting and imaging of cell death both in vitro and in vivo, utilizing NST-732, a member of the ApoSense family, comprising a fluorophore and a fluorine atom, for both fluorescent and future positron emission tomography (PET) studies using an 18F label, respectively. In vitro, NST-732 manifested selective and rapid accumulation within various cell types undergoing apoptosis. Its uptake was blocked by caspase inhibition, and occurred from the early stages of the apoptotic process, in parallel to binding of Annexin-V, caspase activation and alterations in mitochondrial membrane potential. In vivo, NST-732 manifested selective uptake into cells undergoing cell-death in several clinically-relevant models in rodents: (i) Cell-death induced in lymphoma by irradiation; (ii) Renal ischemia/reperfusion; (iii) Cerebral stroke. Uptake of NST-732 was well-correlated with histopathological assessment of cell-death. NST-732 therefore represents a novel class of small-molecule detectors of apoptosis, with potential useful applications in imaging of the cell death process both in vitro and in vivo.
- Open Access
- 1 December 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (51) , 49799-49807
Anti-semaphorin 3A Antibodies Rescue Retinal Ganglion Cells from Cell Death following Optic Nerve Axotomy
- 1 December 2002
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (51) , 49799-49807
Open AccessAnti-semaphorin 3A Antibodies Rescue Retinal Ganglion Cells from Cell Death following Optic Nerve Axotomy